27:
139:
594:(SOSA). Since 2000, the company has sponsored the WAO Henning Løwenstein Research Award which is awarded to a young scientist who has shown excellence within the field of allergy. Since 2005, the award has been made every two years. The 2013 winner, received €10,000 (or an educational grant of corresponding value) and a travel grant to attend the 2013
230:øbenhavn. The company has since focused on mapping the mechanisms of allergic impact on the immune system in order to develop new and improved allergy therapies. The research focuses on prevention, treatment, and management of allergies, especially hay fever and asthma. In 1925, Juan Abello Pascual founded Abello Pharmaceuticals in Spain.
526:
which covered ALK's diagnostic skin prick test for house dust mite allergy, and a subcutaneous immunotherapy (SCIT) product, also for house dust mite allergy. Under the agreement, Eddingpharm handled sales and distribution, while ALK provided medical and scientific expertise. Announced in April 2014,
643:
1992: ALK acquires
Alergia e Immunologia Abello S.A. (Abello), a Spanish company based in Madrid (with additional locations in Italy and Germany), its largest competitor at the time. Abello Pharmaceuticals was founded in 1925 by pharmacist Juan Abello Pascual and specialized in manufacturing oxygen-
237:
drops (allergy immunotherapy administered as droplets under the tongue). In recent years, ALK's research and development strategy has been focused on introducing a range of sublingual immunotherapy tablets (SLIT-tablets). The first, for grass pollen allergy, was launched in 2006, and was followed by
664:
2011: An agreement with Torii
Pharmaceutical Co., Ltd. to develop, register and commercialize a number of SLIT-tablet products in Japan is signed. The agreement also covers selected existing ALK products and diagnostics against house dust mite allergy. It also covers a research and development
534:
covering Russia and selected emerging markets, under which Abbott gains rights to distribute and commercialize ALK's SLIT-tablets for grass, ragweed, tree and house dust mite allergies. The agreement with Abbott was expanded in 2016, allowing Abbott to register and sell ALK's house dust mite
698:
Since launching the first SLIT-tablet (for grass allergy) in 2006, ALK has been developing tablets for other allergies, including tree, ragweed and house dust mite. Its strategy is to develop more patient-friendly treatments based on the approach of 're-educating' the immune system.
507:. The agreement covers the house dust mite SLIT-tablet, an injection-based immunotherapy product, and diagnostic products for house dust mite allergy. In addition, it established a research and development collaboration to develop a SLIT-tablet product for
640:
1990: The PAT (Preventative
Allergy Treatment) study is initiated in collaboration with leading European allergy specialists. The study finds that allergy immunotherapy decreases the risk of the development of asthma in children with allergic
426:
Sublingual immunotherapy drops (SLIT-drops). A droplet-based allergy vaccine marketed under various brand names and covering approximately 40 different allergens and combinations of allergens, including pollens, molds, mites and
1158:
527:
the collaboration was to run for an initial seven years, provided certain performance targets were met. However, the agreement was terminated by ALK in 2016, in favor of a collaboration with a new distributor.
1132:
1307:
591:
233:
In 1978, ALK released the first standardized line of products for the treatment of allergies. In 1992, ALK and Abello merged. In the 1990s, ALK was the first company to launch
684:
2018: Launch of sister brand. Launch of ALK's sister brand klarify.me - offering a broad range of pre-screened products and services to help people manage their allergies.
433:(SCIT). An injection-based allergy vaccine marketed under various brand names and covering the most common allergens such as pollens, molds, mites, pets, bees and wasps.
358:
ALK employs 2,900 people worldwide. The company's global headquarters and its main research and development center are on the Scion DTU science and technology park in
678:
2017: Inclusion in GINA. For the first time, allergy immunotherapy is recommended as a treatment option in the Global
Initiative for Asthma (GINA) strategy document.
1372:
1352:
660:
2009: The Grazax Asthma
Prevention (GAP) trial, investigating the potential for preventing the development of asthma in children and adolescents is initiated.
658:
in
November 2009) to develop, register and commercialize in North America a portfolio of SLIT-tablet treatments for grass, ragweed and house dust mite allergy
1504:
275:, Member of the Remuneration & Nomination Committee, Member of the Scientific Committee, CEO Lundbeckfonden and directorships at two other subsidiaries)
198:. It is one of the world's largest makers of allergy immunotherapy products (also known as ‘allergy vaccines’) with 67% of its revenue coming from sales in
681:
2017: New transformational growth strategy. ALK launches a new strategy to reach out to more people with allergy to become a broader-based allergy company.
578:
which grants it exclusive rights to promote and sell ALK's SLIT-tablets against house dust mite and grass pollen allergy and its adrenaline auto-injector.
1499:
595:
587:
503:
The company also has an alliance with Torii
Pharmaceutical Co. Ltd to develop and commercialize ALK's house dust mite allergy immunotherapy products in
1514:
453:
107:
1031:
673:
2016: ALK expands its partnership with Abbott to cover seven markets in South-East Asia and terminates its partnerships with Merck and EddingPharm.
863:
783:
628:
1949: Production of allergy vaccines and diagnostics is centered at an independent unit called
Allergologisk Laboratorium (Allergology Laboratory)
1484:
1509:
523:
1489:
1332:
1311:
1207:
1109:
1494:
1056:
687:
2021: Entering food allergies. ALK announces an entry into food allergy treatment and begins developing a tablet for peanut allergies.
638:
1990: The world's first product for sublingual immunotherapy drops (SLIT-drops) (droplets administered under the tongue) is launched
1412:
1392:
1184:
636:
1984: ALK begins a period of global expansion by establishing a presence in several new markets and through strategic acquisitions
1081:
927:
907:
618:
1923: Doctor Kaj Baagøe and pharmacist Peter Barfod produce
Denmark's first pharmaceutically manufactured allergen extract at
268:, Chairperson of the Remuneration & Nomination Committee, Member of the Scientific Committee, Professional board member)
669:
2014: ALK signs collaboration agreements with
Eddingpharm for China and Abbott for Russia and selected emerging markets.
1287:
648:
2006: The world's first registered sublingual immunotherapy tablet (SLIT-tablet), for grass pollen allergy, is launched
630:
1972: The technique to accurately identify the proteins that provoke allergies in individual patients is developed
437:
The aforementioned allergy immunotherapy products are purified from natural allergen sources then combined with
988:
968:
619:
215:
1011:
1267:
290:
Alan Main (Member of the Remuneration & Nomination Committee, Senior adviser, Bamboo Capital Partners)
272:
1035:
309:
671:
2015: ALK signs a collaboration agreement with bioCSL (now Seqirus) covering Australia and New Zealand.
599:
456:, and bulk allergen extracts, mostly sold in the US to allergy specialists for use in their practices.
430:
179:
55:
1247:
416:
Allergy immunotherapy products account for 88% of ALK's revenues and comprise three types of product:
662:
2011: A new ALK-developed adrenaline auto-injector for the treatment of acute anaphylaxis is launched
384:
363:
255:
740:
646:
2000: Acquires Center Laboratories, one of the leading suppliers of allergenic extracts in the U.S.
445:
420:
324:
320:
234:
644:
and alkaline-based therapeutics as well as synthetic hormones, among other processes and products.
334:
313:
239:
118:
287:
Bertil Lindmark (Chairperson of the Scientific Committee, Chief Medical Officer of Galecto A/S)
590:(EAACI). It also sponsors and organizes an invitation-only biennial scientific symposium, the
376:
European production facilities in Hørsholm, Denmark, in Vanduille and Varennes, France, and in
187:
1060:
947:
823:
760:
344:
265:
191:
1153:
1151:
796:
665:
contract to develop a sublingual immunotherapy tablet against Japanese cedar pollen allergy.
423:
tablets (SLIT-tablets) covering grass pollen, ragweed pollen and house dust mite allergies.
1227:
8:
1148:
803:
531:
1057:"All rights to ALK's SLIT-tablets in North America to revert to ALK from MSD (OMX:ALKB)"
690:
2023: ALK turns 100 years. ALK has been a pioneer in fighting allergies for 100 years.
284:
Jesper Høiland (Member of the Audit Committee, Strategic adviser, PharmaCo Consult ApS)
465:
1085:
843:
278:
Gitte Aabo (Chairperson of the Audit Committee, CEO of GN Hearing and GN Store Nord)
485:
388:
111:
883:
651:
536:
489:
632:
1976: The first standardized process for allergen extracts (DAS 76) is developed
655:
623:
508:
65:
634:
1978: The world's first standardized allergy immunotherapy product is launched
1478:
519:
497:
473:
469:
400:
369:
The company is present in 46 countries, either directly or via partnerships.
175:
51:
45:
262:
As of November 1, 2023, the current members of ALK's board of directors are:
1024:
142:
37:
1439:
281:
Lars Holmqvist (Member of the Audit Committee, Professional board member)
575:
556:
548:
449:
961:
570:
ALK also signed a collaboration with bioCSL (now name Seqirus) covering
488:
to develop, market and distribute the tablets for grass pollen allergy,
359:
94:
1202:
1200:
675:
2016: The house dust mite SLIT-tablet is launched in Europe and Japan.
392:
76:
26:
1179:
1177:
340:
Christian Gauguin Houghton (Executive Vice President, Product Supply)
1405:
1325:
1074:
571:
552:
540:
438:
306:
As of November 1, 2023, the members of ALK's board of management are:
1300:
1197:
1104:
1102:
1385:
1365:
1345:
1174:
564:
544:
404:
350:
Jan Engel Jensen (Senior Vice President, Global Quality Assurance)
243:
211:
920:
1099:
804:"Jacobsen K. "From Goose Feathers to Grazax- The History of ALK""
493:
195:
183:
981:
667:
2014: The grass and ragweed SLIT-tablets are launched in the US.
900:
560:
481:
477:
472:
to develop and commercialize ALK's SLIT-tablet products in the
377:
330:
Søren Niegel (Executive Vice President, Commercial Operations)
199:
1280:
753:
607:
603:
515:
504:
500:
announced that the partnership would end by the end of 2016.
396:
1006:
1004:
1260:
1220:
1159:"ALK R&D and business briefing, slide 59 (21 May 2014)"
190:
which specializes in the development and manufacturing of
1127:
1125:
1001:
1240:
735:
733:
731:
1122:
729:
727:
725:
723:
721:
719:
717:
715:
713:
711:
246:
Foundation, however is also a publicly traded entity.
1467:
238:
SLIT-tablets for ragweed pollen allergy in 2014, and
163:
210:
ALK-Abello dates back to 1923, when Denmark's first
708:
596:
European Academy of Allergy and Clinical Immunology
588:
European Academy of Allergy and Clinical Immunology
194:(AIT) products for the prevention and treatment of
459:
1476:
496:allergy in those markets. In June 2016, ALK and
129:Acarizax, Grazax, SlitOneUltra, Alutard SQ, Jext
218:. The company was subsequently established as
214:extracts were produced at the pharmacy of the
1032:"Worldwide Alliances, Merck & Co website"
1505:Pharmaceutical companies established in 1923
693:
1500:Life science companies based in Copenhagen
969:"Allergy emergency treatment, ALK website"
586:ALK is one of the founder sponsors of the
452:, allergy diagnostic kits, for example,
242:in 2016. The company is part-owned by the
25:
1515:Companies based in Rudersdal Municipality
444:Other ALK products include an emergency
383:North American production facilities in
254:ALK's stock is listed on the NASDAQ OMX
249:
1333:"ALK media release (06 September 2011)"
1082:"Torii media release (28 January 2011)"
702:
1477:
1308:"ALK media release (16 November 2009)"
1208:"ALK media release (09 February 2015)"
1485:Companies listed on Nasdaq Copenhagen
1434:
1432:
1430:
1428:
1393:"ALK media release (27 January 2016)"
1373:"Merck Media release (17 April 2014)"
1353:"Merck Media release (14 April 2014)"
1185:"ALK media release (28 January 2016)"
1510:Danish companies established in 1923
928:"Subcutaneous vaccines, ALK website"
778:
776:
182:), also commonly known as ALK, is a
1490:Pharmaceutical companies of Denmark
1110:"ALK media release (25 April 2014)"
13:
1495:Biotechnology companies of Denmark
1425:
989:"Allergy diagnostics, ALK website"
908:"Sublingual vaccines, ALK website"
650:2007: An agreement is signed with
530:ALK also has a collaboration with
14:
1526:
1459:
1413:"ALK media release (28 Sep 2015)"
773:
761:"Stallergenes Annual Report 2012"
1288:"Former recipients, ALK website"
535:SLIT-tablet in seven markets in
464:From 2006 until 2016, ALK had a
138:
137:
86:Kaj Hedemann Baagøe Peter Barfod
1049:
940:
581:
460:Partnerships and collaborations
876:
856:
844:"Board of Management, alk.net"
836:
816:
620:Copenhagen University Hospital
372:Other ALK facilities include:
337:and Executive Vice President)
216:Copenhagen University Hospital
1:
1268:"Research award, ALK website"
1228:"Organization, EAACI website"
824:"Board of Directors, alk.net"
592:Symposium on Specific Allergy
353:
347:, People & Organisation)
16:Danish pharmaceutical company
1059:. 2016-08-17. Archived from
7:
1012:"Partnerships, ALK website"
613:
411:
10:
1531:
600:World Allergy Organization
448:for people who experience
431:Subcutaneous immunotherapy
399:, in Luther, Iowa, and in
205:
1248:"Congresses, ALK website"
364:Capital Region of Denmark
256:Copenhagen Stock Exchange
159:
149:
133:
125:
101:
90:
82:
71:
61:
43:
33:
24:
1133:"ALK Annual Report 2016"
694:Research and development
421:Sublingual immunotherapy
325:Research and Development
321:Executive Vice President
266:Chairperson of the board
235:sublingual immunotherapy
884:"Global presence | ALK"
446:adrenaline autoinjector
335:Chief Financial Officer
314:Chief Executive Officer
240:house dust mite allergy
741:"History, ALK website"
333:Claus Steensen Sølje (
188:pharmaceutical company
345:Senior Vice President
319:Henriette Mersebach (
299:Lise Lund Mærkedahl
250:Corporate information
192:allergy immunotherapy
864:"Annual report 2023"
784:"Annual report 2023"
703:Notes and references
441:during formulation.
145:4.824 billion (2023)
654:(which merged with
151:Number of employees
21:
602:(WAO) Congress in
466:strategic alliance
362:, Denmark, in the
264:Anders Hedegaard (
19:
484:, granting Merck
176:Nasdaq Copenhagen
169:
168:
121:
114:
52:Nasdaq Copenhagen
1522:
1471:
1470:
1468:Official website
1454:
1453:
1451:
1450:
1436:
1423:
1422:
1420:
1419:
1409:
1403:
1402:
1400:
1399:
1389:
1383:
1382:
1380:
1379:
1369:
1363:
1362:
1360:
1359:
1349:
1343:
1342:
1340:
1339:
1329:
1323:
1322:
1320:
1319:
1310:. Archived from
1304:
1298:
1297:
1295:
1294:
1284:
1278:
1277:
1275:
1274:
1264:
1258:
1257:
1255:
1254:
1244:
1238:
1237:
1235:
1234:
1224:
1218:
1217:
1215:
1214:
1204:
1195:
1194:
1192:
1191:
1181:
1172:
1171:
1169:
1168:
1163:
1155:
1146:
1145:
1143:
1142:
1137:
1129:
1120:
1119:
1117:
1116:
1106:
1097:
1096:
1094:
1093:
1084:. Archived from
1078:
1072:
1071:
1069:
1068:
1053:
1047:
1046:
1044:
1043:
1034:. Archived from
1028:
1022:
1021:
1019:
1018:
1008:
999:
998:
996:
995:
985:
979:
978:
976:
975:
965:
959:
958:
956:
954:
944:
938:
937:
935:
934:
924:
918:
917:
915:
914:
904:
898:
897:
895:
894:
880:
874:
873:
871:
870:
860:
854:
853:
851:
850:
840:
834:
833:
831:
830:
820:
814:
813:
811:
810:
800:
794:
793:
791:
790:
780:
771:
770:
768:
767:
757:
751:
750:
748:
747:
737:
511:pollen allergy.
486:exclusive rights
454:skin prick tests
141:
140:
117:
110:
108:Anders Hedegaard
29:
22:
18:
1530:
1529:
1525:
1524:
1523:
1521:
1520:
1519:
1475:
1474:
1466:
1465:
1462:
1457:
1448:
1446:
1440:"History | ALK"
1438:
1437:
1426:
1417:
1415:
1411:
1410:
1406:
1397:
1395:
1391:
1390:
1386:
1377:
1375:
1371:
1370:
1366:
1357:
1355:
1351:
1350:
1346:
1337:
1335:
1331:
1330:
1326:
1317:
1315:
1306:
1305:
1301:
1292:
1290:
1286:
1285:
1281:
1272:
1270:
1266:
1265:
1261:
1252:
1250:
1246:
1245:
1241:
1232:
1230:
1226:
1225:
1221:
1212:
1210:
1206:
1205:
1198:
1189:
1187:
1183:
1182:
1175:
1166:
1164:
1161:
1157:
1156:
1149:
1140:
1138:
1135:
1131:
1130:
1123:
1114:
1112:
1108:
1107:
1100:
1091:
1089:
1080:
1079:
1075:
1066:
1064:
1055:
1054:
1050:
1041:
1039:
1030:
1029:
1025:
1016:
1014:
1010:
1009:
1002:
993:
991:
987:
986:
982:
973:
971:
967:
966:
962:
952:
950:
948:"Raw Materials"
946:
945:
941:
932:
930:
926:
925:
921:
912:
910:
906:
905:
901:
892:
890:
882:
881:
877:
868:
866:
862:
861:
857:
848:
846:
842:
841:
837:
828:
826:
822:
821:
817:
808:
806:
802:
801:
797:
788:
786:
782:
781:
774:
765:
763:
759:
758:
754:
745:
743:
739:
738:
709:
705:
696:
674:
672:
670:
668:
666:
663:
661:
659:
656:Merck & Co.
652:Schering-Plough
649:
647:
645:
642:
639:
637:
635:
633:
631:
629:
627:
616:
584:
549:the Philippines
537:South-East Asia
490:house dust mite
462:
414:
385:Port Washington
356:
308:Peter Halling (
307:
305:
302:Johan Smedsrud
263:
261:
252:
208:
152:
115:
104:
66:Pharmaceuticals
48:
17:
12:
11:
5:
1528:
1518:
1517:
1512:
1507:
1502:
1497:
1492:
1487:
1473:
1472:
1461:
1460:External links
1458:
1456:
1455:
1424:
1404:
1384:
1364:
1344:
1324:
1299:
1279:
1259:
1239:
1219:
1196:
1173:
1147:
1121:
1098:
1073:
1048:
1023:
1000:
980:
960:
939:
919:
899:
875:
855:
835:
815:
795:
772:
752:
706:
704:
701:
695:
692:
624:Rigshospitalet
615:
612:
583:
580:
509:Japanese cedar
498:Merck & Co
470:Merck & Co
461:
458:
435:
434:
428:
424:
413:
410:
409:
408:
381:
355:
352:
343:Lisbeth Kirk (
296:Nanna Carlson
293:Katja Barnkob
251:
248:
207:
204:
172:ALK-Abelló A/S
167:
166:
161:
157:
156:
153:
150:
147:
146:
135:
131:
130:
127:
123:
122:
116:Peter Halling
105:
102:
99:
98:
92:
88:
87:
84:
80:
79:
73:
69:
68:
63:
59:
58:
49:
44:
41:
40:
35:
31:
30:
20:ALK-Abelló A/S
15:
9:
6:
4:
3:
2:
1527:
1516:
1513:
1511:
1508:
1506:
1503:
1501:
1498:
1496:
1493:
1491:
1488:
1486:
1483:
1482:
1480:
1469:
1464:
1463:
1445:
1441:
1435:
1433:
1431:
1429:
1414:
1408:
1394:
1388:
1374:
1368:
1354:
1348:
1334:
1328:
1314:on 2016-03-04
1313:
1309:
1303:
1289:
1283:
1269:
1263:
1249:
1243:
1229:
1223:
1209:
1203:
1201:
1186:
1180:
1178:
1160:
1154:
1152:
1134:
1128:
1126:
1111:
1105:
1103:
1088:on 2014-02-23
1087:
1083:
1077:
1063:on 2016-08-17
1062:
1058:
1052:
1038:on 2015-07-07
1037:
1033:
1027:
1013:
1007:
1005:
990:
984:
970:
964:
949:
943:
929:
923:
909:
903:
889:
885:
879:
865:
859:
845:
839:
825:
819:
805:
799:
785:
779:
777:
762:
756:
742:
736:
734:
732:
730:
728:
726:
724:
722:
720:
718:
716:
714:
712:
707:
700:
691:
688:
685:
682:
679:
676:
657:
653:
625:
621:
611:
609:
605:
601:
597:
593:
589:
579:
577:
573:
568:
566:
562:
558:
554:
550:
546:
542:
538:
533:
528:
525:
521:
520:collaboration
517:
512:
510:
506:
501:
499:
495:
491:
487:
483:
479:
475:
474:United States
471:
467:
457:
455:
451:
447:
442:
440:
432:
429:
425:
422:
419:
418:
417:
406:
402:
401:Oklahoma City
398:
394:
390:
386:
382:
379:
375:
374:
373:
370:
367:
365:
361:
351:
348:
346:
341:
338:
336:
331:
328:
326:
322:
317:
315:
311:
303:
300:
297:
294:
291:
288:
285:
282:
279:
276:
274:
269:
267:
259:
257:
247:
245:
241:
236:
231:
229:
225:
222:llergologisk
221:
217:
213:
203:
201:
197:
193:
189:
185:
181:
177:
173:
165:
162:
158:
154:
148:
144:
136:
132:
128:
124:
120:
113:
109:
106:
100:
96:
93:
89:
85:
81:
78:
74:
70:
67:
64:
60:
57:
53:
50:
47:
42:
39:
36:
32:
28:
23:
1447:. Retrieved
1443:
1416:. Retrieved
1407:
1396:. Retrieved
1387:
1376:. Retrieved
1367:
1356:. Retrieved
1347:
1336:. Retrieved
1327:
1316:. Retrieved
1312:the original
1302:
1291:. Retrieved
1282:
1271:. Retrieved
1262:
1251:. Retrieved
1242:
1231:. Retrieved
1222:
1211:. Retrieved
1188:. Retrieved
1165:. Retrieved
1139:. Retrieved
1113:. Retrieved
1090:. Retrieved
1086:the original
1076:
1065:. Retrieved
1061:the original
1051:
1040:. Retrieved
1036:the original
1026:
1015:. Retrieved
992:. Retrieved
983:
972:. Retrieved
963:
951:. Retrieved
942:
931:. Retrieved
922:
911:. Retrieved
902:
891:. Retrieved
887:
878:
867:. Retrieved
858:
847:. Retrieved
838:
827:. Retrieved
818:
807:. Retrieved
798:
787:. Retrieved
764:. Retrieved
755:
744:. Retrieved
697:
689:
686:
683:
680:
677:
617:
585:
582:Sponsorships
569:
529:
518:, ALK had a
513:
502:
492:allergy and
463:
443:
436:
415:
371:
368:
357:
349:
342:
339:
332:
329:
318:
304:
301:
298:
295:
292:
289:
286:
283:
280:
277:
271:Lene Skole (
270:
260:
253:
232:
227:
226:aboratorium
223:
219:
209:
171:
170:
155:2,900 (2023)
91:Headquarters
38:Aktieselskab
34:Company type
1444:www.alk.net
888:www.alk.net
576:New Zealand
557:South Korea
524:Eddingpharm
450:anaphylaxis
164:www.alk.net
1479:Categories
1449:2023-08-15
1418:2017-06-20
1398:2017-06-20
1378:2017-05-30
1358:2017-05-30
1338:2014-04-08
1318:2014-02-20
1293:2014-02-20
1273:2014-02-20
1253:2013-06-27
1233:2014-02-20
1213:2015-02-23
1190:2017-05-30
1167:2014-06-12
1141:2017-05-30
1115:2014-06-12
1092:2014-02-20
1067:2023-03-01
1042:2013-06-27
1017:2013-06-27
994:2013-06-27
974:2013-06-27
933:2013-06-27
913:2013-06-27
893:2023-02-08
869:2023-02-08
849:2023-08-15
829:2023-08-15
809:2014-02-20
789:2024-02-08
766:2013-06-17
746:2013-06-27
439:excipients
393:Post Falls
354:Operations
273:Vice Chair
112:(Chairman)
103:Key people
77:Copenhagen
572:Australia
553:Singapore
541:Hong Kong
310:President
97:, Denmark
46:Traded as
641:rhinitis
614:Timeline
598:(EAACI)/
565:Thailand
545:Malaysia
412:Products
405:Oklahoma
389:New York
380:, Spain.
360:Hørsholm
244:Lundbeck
212:allergen
126:Products
95:Hørsholm
62:Industry
494:ragweed
206:History
196:allergy
186:-based
184:Denmark
178::
160:Website
134:Revenue
83:Founder
72:Founded
54::
561:Taiwan
532:Abbott
482:Mexico
478:Canada
378:Madrid
200:Europe
1162:(PDF)
1136:(PDF)
953:1 May
608:Italy
604:Milan
522:with
516:China
505:Japan
468:with
427:pets.
397:Idaho
391:, in
180:ALK B
119:(CEO)
75:1923
56:ALK B
955:2014
574:and
563:and
480:and
312:and
514:In
143:DKK
1481::
1442:.
1427:^
1199:^
1176:^
1150:^
1124:^
1101:^
1003:^
886:.
775:^
710:^
610:.
606:,
567:.
559:,
555:,
551:,
547:,
543:,
539::
476:,
403:,
395:,
387:,
366:.
327:)
323:,
316:)
258:.
202:.
1452:.
1421:.
1401:.
1381:.
1361:.
1341:.
1321:.
1296:.
1276:.
1256:.
1236:.
1216:.
1193:.
1170:.
1144:.
1118:.
1095:.
1070:.
1045:.
1020:.
997:.
977:.
957:.
936:.
916:.
896:.
872:.
852:.
832:.
812:.
792:.
769:.
749:.
626:)
622:(
407:.
228:K
224:L
220:A
174:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
